MORGAN STANLEY PLC/CALL/PFIZER INC/40.5/0.1/17.01.25 Stock

Warrant

DE000MB333E1

Market Closed - Börse Stuttgart 14:13:01 2024-07-02 EDT
0.021 EUR -4.55% Intraday chart for MORGAN STANLEY PLC/CALL/PFIZER INC/40.5/0.1/17.01.25
Current month+4.76%
1 month-4.35%
Date Price Change
24-07-02 0.021 -4.55%
24-07-01 0.022 +4.76%
24-06-28 0.021 -4.55%
24-06-27 0.022 +10.00%
24-06-26 0.02 +11.11%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 02:13 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB333E
ISINDE000MB333E1
Date issued 2023-02-01
Strike 40.5 $
Maturity 2025-01-17 (199 Days)
Parity 10 : 1
Emission price 0.93
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.79
Lowest since issue 0.016
Delta0.1x
Omega 8.636
Premium46.7x
Gearing84.91x
Moneyness 0.6872
Difference Strike 12.67 $
Difference Strike %+31.28%
Spread 0.019
Spread %47.50%
Theoretical value 0.0305
Implied Volatility 36.47 %
Total Loss Probability 93.68 %
Intrinsic value 0.000000
Present value 0.0305
Break even 40.83 €
Theta-0x
Vega0x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.22 USD
Average target price
31.92 USD
Spread / Average Target
+13.10%
Consensus